NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery-a prospective analysis

Obesity Surgery

Volumn 21, Issue 3, 2011, Pages 310-315

  Ribeireiro, Tarsila ^a   Swain, James ^a   Sarr, Michael ^a   Kendrick, Michael ^a   Que, Florencia ^a   Sanderson, Schuyler ^a   Krishnan, Anuradha ^a   Viker, Kimberly ^a   Watt, Kymberly ^a   Charlton, Michael ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bariatric surgery; Hepatic histopathology; Morbid obesity; NAFLD; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANASTOMOSIS STENOSIS; ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GASTRIC BANDING; GENDER; HUMAN; HYPERTENSION; INCISIONAL HERNIA; INSULIN RESISTANCE; INTRAOPERATIVE PERIOD; LAPAROSCOPIC SURGERY; LIVER BIOPSY; LIVER FAILURE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; RISK FACTOR; ROUX Y ANASTOMOSIS; SLEEP APNEA SYNDROME; SMALL INTESTINE OBSTRUCTION; STOMACH BYPASS; SURGICAL APPROACH; SURGICAL INFECTION; SURGICAL RISK; THERAPY EFFECT;

ADULT; AGED; BILIOPANCREATIC DIVERSION; FATTY LIVER; FEMALE; GASTRIC BYPASS; GASTROPLASTY; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 79955767080     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-010-0228-6     Document Type: Article

References (44)

1. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994 [see comments]. Diab Care. 1998;21:518-24. (Pubitemid 28172927)
2. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med. 2003;163:2146-8. (Pubitemid 37248778)
3. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-93. (Pubitemid 39665322)
4. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-52. (Pubitemid 47295641)
5. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: Surgical treatment of obesity. Ann Intern Med. 2005;142:547-59.
6. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40:S5-10. (Pubitemid 44309537)
7. Angulo P. Nonalcoholic fatty liver disease [comment]. N Engl J Med. 2002;346:1221-31 [Review] [95 refs]. (Pubitemid 34984585)
8. Charlton M. Nonalcoholic fatty liver disease: A review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004;2:1048-58 [Review] [117 refs]. (Pubitemid 40037633)
9. Noel M, Hickner J, Ettenhofer T, et al. The high prevalence of obesity in Michigan primary care practices. An UPRNet study. Upper Peninsula Research Network. J Fam Pract. 1998;47:39-43. (Pubitemid 28328784)
10. Flegal KM. The obesity epidemic in children and adults: Current evidence and research issues. Med Sci Sports Exerc. 1999;31(11 Suppl):S509-14 [Review] [47 refs].
11. Popkin BM, Udry JR. Adolescent obesity increases significantly in second and third generation U.S. immigrants: The National Longitudinal Study of Adolescent Health. J Nutr. 1998;128:701-6. (Pubitemid 28158483)
12. Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007;133:1814-20. (Pubitemid 350186161)
13. Wolf AM, Busch B, Kuhlmann HW, et al. Histological changes in the liver of morbidly obese patients: Correlation with metabolic parameters. Obes Surg. 2005;15:228-37. (Pubitemid 40316009)
14. Lima ML, Mourao SC, Diniz MT, et al. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass. Obes Surg. 2005;15:661-9. (Pubitemid 40847957)
15. Harnois F, Msika S, Sabate JM, et al. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery. Obes Surg. 2006;16:183-8.
16. Papadia FS, Marinari GM, Camerini G, et al. Liver damage in severely obese patients: A clinical-biochemical-morphologic study on 1, 000 liver biopsies. Obes Surg. 2004;14:952-8. (Pubitemid 39093470)
17. Sorrentino P, Tarantino G, Conca P, et al. Silent non-alcoholic fatty liver disease-a clinical-histological study. J Hepatol. 2004;41:751-7. (Pubitemid 39434304)
18. Adams LA, Lymp JF, St S, et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology. 2005;129:113-21 [see comment]. (Pubitemid 41002048)
19. Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg. 2003;7:1034-44. (Pubitemid 37524071)
20. Castillo J, Fabrega E, Escalante CF, et al. Liver transplantation in a case of steatohepatitis and subacute hepatic failure after biliopancreatic diversion for morbid obesity. Obes Surg. 2001;11:640-2. (Pubitemid 32907138)
21. Mason EE, Renquist KE, Huang YH, et al. Causes of 30-day bariatric surgery mortality: With emphasis on bypass obstruction. Obes Surg. 2007;17:9-14.
22. Grimm IS, Schindler W, Haluszka O. Steatohepatitis and fatal hepatic failure after biliopancreatic diversion. Am J Gastroenterol. 1992;87:775-9.
23. Thorell A, Nygren J, Ljungqvist O. Insulin resistance: A marker of surgical stress. Curr Opin Clin Nutr Metab Care. 1999;2:69-78. (Pubitemid 129628628)
24. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356-61. (Pubitemid 27084552)
25. Gravante G, Araco A, Araco F, et al. Postobese patients and inherent surgical complications. Ann Plast Surg. 2006;56:585-6. (Pubitemid 43970251)
26. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med. 2003;31:359-66. (Pubitemid 36232926)
27. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956-61.
28. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. Jama. 2003;289:2560-72. (Pubitemid 37430158)
29. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13 Suppl 1:1-68.
30. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-8. (Pubitemid 38133916)
31. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467-74. (Pubitemid 29420675)
32. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en- Y- 500 patients: Technique and results, with 3-60 month followup. Obes Surg. 2000;10:233-9.
33. Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: A randomized study of outcomes, quality of life, and costs. Ann Surg. 2001;234:279-89. discussion 289-91.
34. Westling A, Gustavsson S. Laparoscopic vs open Roux-en-Y gastric bypass: A prospective, randomized trial. Obes Surg. 2001;11:284-92. (Pubitemid 32607217)
35. Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: A population-based analysis. J Am Coll Surg. 2004;199:543-51. (Pubitemid 39420204)
36. Weller WE, Rosati C, Hannan EL. Relationship between surgeon and hospital volume and readmission after bariatric operation. J Am Coll Surg. 2007;204:383-91.
37. Dimick JB, Welch HG, Birkmeyer JD. Surgical mortality as an indicator of hospital quality: The problem with small sample size. Jama. 2004;292:847-51. (Pubitemid 39079671)
38. Livingston EH, Huerta S, Arthur D, et al. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg. 2002;236:576-82. (Pubitemid 35246889)
39. Jamal MK, DeMaria EJ, Johnson JM, et al. Impact of major comorbidities on mortality and complications after gastric bypass. Surg Obes Relat Dis. 2005;1:511-6.
40. Fernandez AZ Jr, Demaria EJ, Tichansky DS, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239:698-702. discussion 702-693.
41. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909-17. (Pubitemid 41464692)
42. Lancaster RT, Hutter MM. Bands and bypasses: 30-day morbidity and mortality of bariatric surgical procedures as assessed by prospective, multi-center, risk-adjusted ACS-NSQIP data. Surg Endosc. 2008;22:2554-63.
43. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21. (Pubitemid 40770284)
44. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413-9. (Pubitemid 29258890)